Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -29.12% is 50% above its 5-year average of -58.06%, near the high end of its 5-year range (-3954.45%–100.00%).
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
-29.12%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
-58.06%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+49.85%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-170.67%
vs the sector median at left
Market Cap
$51.99M
Gross Margin
N/A
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
16.67%
Market Cap
$51.19M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$52.60M
Gross Margin
20.51%
TTM Avg
34.75%
3Y Avg
47.46%
5Y Avg
49.68%
Market Cap
$51.12M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$50.27M
Gross Margin
-262.66%
TTM Avg
-246.22%
3Y Avg
-188.06%
5Y Avg
-150.05%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImageneBio Inc (IMA) | $51.88M | -29.12% | 0.00% | 0.00% | -58.06% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | 50.00% | 25.00% | 16.67% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | 20.51% | 34.75% | 47.46% | 49.68% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | 41.51% | 45.14% | 44.16% | 37.16% |
| biote Corp. (BTMD)vs › | $50.28M | 71.46% | 70.99% | 69.42% | 67.35% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -262.66% | -246.22% | -188.06% | -150.05% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-29.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 53.72% |
| 2023-09-30 | 79.58% |
| 2023-06-30 | -607.98% |
| 2023-03-31 | -192.72% |
| 2022-12-31 | -186.95% |
| 2022-09-30 | -194.44% |
| 2022-06-30 | -3954.45% |
| 2022-03-31 | -323.85% |
| 2021-12-31 | 38.97% |
| 2021-09-30 | -257.05% |
| 2021-06-30 | -220.48% |
| 2021-03-31 | -188.46% |
| 2020-12-31 | -35903.08% |
| 2020-09-30 | -155.14% |
| 2020-06-30 | -106.12% |
| 2020-03-31 | -144.59% |
| 2019-12-31 | -112.70% |
